- Shareholders approved corporate name change to Mentari Therapeutics, Inc.
- Approved share consolidation (reverse split) to maintain compliance and restructuring
- Routine AGM proposals and director elections passed with broad support
Signal #144880 · SEC 8-K
$INM SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $INM filing catalyst
Why did $INM trigger an AI stock catalyst alert?
$INM triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: InMed Pharmaceuticals Approves Name Change to Mentari Therapeutics and Share Consolidation. Key points: - Shareholders approved corporate name change to Mentari Therapeutics, Inc. - Approved share consolidation (reverse split) to maintain compliance and restructuring - Routine AGM proposals and director elections passed with broad support
How did $INM stock react after the SEC filing?
After the SEC 8-K for $INM, observed market reaction: T0 price $17.50. Past moves do not guarantee future results.
Where can I get real-time $INM SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $INM via Telegram and the VIP Web Terminal from €10/month.